EUROLAB laboratory provides testing and compliance service within the scope of USP 797 standard. Millions of drugs are combined each year in the United States to meet the unique needs of patients. The composition provides access to the drug for patients who are unable to use commercially available formulations due to dose requirements, allergies, or rare diseases.
Medications that must be sterile include those administered by injection, intravenous infusion (IV), intraocular (injection into the eye), or intrathecal (injection into the spine).
Understanding the risks inherent in sterile compounding and incorporating established standards is essential to patient safety.
Compound drugs made without the guidance of standards can be low-potency, super-strength, or contaminated, putting patients at risk for significant side effects and even death.
USP develops standards for preparing compound sterile drugs to benefit the patient and reduce risks such as contamination, infection, or incorrect dosing.
EUROLAB assists manufacturers with USP 797 test compliance. Our test experts, with their professional working mission and principles, provide you, our manufacturers and suppliers, the best service and controlled testing process in our laboratories. Thanks to these services, businesses receive more effective, high-performance and quality testing services and provide safe, fast and uninterrupted service to their customers.
To get an appointment, to get more detailed information or to request an evaluation, you can ask us to fill in our form and reach you.
EUROLABreporting and certification activities, United Accreditation Foundation (UAF), Turkish Accreditation Agency (TÜRKAK) ve Enterprise Accreditation Foundation (EAF) based on the accreditation provided by the accreditation body. The Enterprise Accreditation Foundation (EAF) accreditation body is also a signatory of the United Nations (UN GLOBAL COMPACT) organization.
